immune-modulating antibody therapeutics (Zymeworks/GlaxoSmithKline)
N/A
Report date: 2025/01/26 17:50:05
Base Information
Drug Nameimmune-modulating antibody therapeutics (Zymeworks/GlaxoSmithKline)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[1] N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZymeworks Inc
China Registration ClassN/A
Develop Information
Active CompaniesZymeworks IncGlaxosmithkline Plc
Inactive CompaniesN/A
Active Indications +[1] N/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A